How are PFE straddle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the PFE straddle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 18.04%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$100.46 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a PFE straddle?

The breakeven for the PFE straddle priced on this page is roughly $25.93 and $28.08 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The PFE market-implied 1-standard-deviation expected move in the same options snapshot is approximately 5.17%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current PFE implied volatility affect this straddle?

PFE ATM IV is at 18.04% with IV rank near 0.30%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

PFE Straddle Strategy

PFE (Pfizer Inc.), in the Healthcare sector, (Drug Manufacturers - General industry), listed on NYSE.

Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX.

PFE (Pfizer Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - General, with a market capitalization of approximately $149.95B, a trailing P/E of 34.59, a beta of 0.28 versus the broader market, a 52-week range of 23.58-28.75, average daily share volume of 40.1M, a public-listing history dating back to 1972, approximately 75K full-time employees. These structural characteristics shape how PFE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.28 indicates PFE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. PFE pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a straddle on PFE?

A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.

PFE snapshot

As of August 14, 2026, spot at $26.79, ATM IV 18.04%, IV rank 0.30%, expected move 5.17%. The straddle on PFE below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this straddle structure on PFE specifically: PFE IV at 18.04% is on the cheap side of its 1-year range, which favors premium-buying structures like a PFE straddle, with a market-implied 1-standard-deviation move of approximately 5.17% (roughly $1.39 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PFE expiries trade a higher absolute premium for lower per-day decay. Position sizing on PFE should anchor to the underlying notional of $26.79 per share and to the trader's directional view on PFE stock.

PFE straddle setup

The PFE straddle below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PFE at $26.79 on that close, the first option leg uses a $27.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PFE chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PFE shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$27.00	$0.48
Buy 1	Put	$27.00	$0.60

PFE straddle risk and reward

Net Premium / Debit: -$107.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$100.46
Breakeven(s): $25.93, $28.08
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.

PFE straddle payoff curve

Modeled P&L at expiration across a range of underlying prices for the straddle on PFE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$2,591.50
$5.93	-77.9%	+$1,999.27
$11.85	-55.7%	+$1,407.04
$17.78	-33.6%	+$814.81
$23.70	-11.5%	+$222.58
$29.62	+10.6%	+$154.66
$35.54	+32.7%	+$746.89
$41.47	+54.8%	+$1,339.12
$47.39	+76.9%	+$1,931.35
$53.31	+99.0%	+$2,523.58

When traders use straddle on PFE

Straddles on PFE are pure-volatility plays that profit from large moves in either direction; traders typically buy PFE straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.

PFE thesis for this straddle

The market-implied 1-standard-deviation range for PFE extends from approximately $25.40 on the downside to $28.18 on the upside. A PFE long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current PFE IV rank near 0.30% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PFE at 18.04%. As a Healthcare name, PFE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PFE-specific events.

PFE straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PFE positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PFE alongside the broader basket even when PFE-specific fundamentals are unchanged. Always rebuild the position from current PFE chain quotes before placing a trade.

Frequently asked questions

What is a straddle on PFE?: A straddle on PFE is the straddle strategy applied to PFE (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With PFE stock at $26.79 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed PFE chain strike and the premiums come straight from that session's bid/ask midpoint.
How are PFE straddle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the PFE straddle priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 18.04%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$100.46 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a PFE straddle?: The breakeven for the PFE straddle priced on this page is roughly $25.93 and $28.08 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The PFE market-implied 1-standard-deviation expected move in the same options snapshot is approximately 5.17%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a straddle on PFE?: Straddles on PFE are pure-volatility plays that profit from large moves in either direction; traders typically buy PFE straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
How does current PFE implied volatility affect this straddle?: PFE ATM IV is at 18.04% with IV rank near 0.30%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.